ATE438722T1 - Verfahren zur herstellung von proteinen unter reduktion von mannosephosphat in der zuckerkette und dadurch hergestelltes glykoprotein - Google Patents

Verfahren zur herstellung von proteinen unter reduktion von mannosephosphat in der zuckerkette und dadurch hergestelltes glykoprotein

Info

Publication number
ATE438722T1
ATE438722T1 AT01930179T AT01930179T ATE438722T1 AT E438722 T1 ATE438722 T1 AT E438722T1 AT 01930179 T AT01930179 T AT 01930179T AT 01930179 T AT01930179 T AT 01930179T AT E438722 T1 ATE438722 T1 AT E438722T1
Authority
AT
Austria
Prior art keywords
sugar chain
reduction
protein
mannose phosphate
glycoprotein
Prior art date
Application number
AT01930179T
Other languages
English (en)
Inventor
Masami Miura
Masaaki Hirose
Taeko Miwa
Hiroyuki Irie
Shinobu Kuwae
Kenmi Miyano
Wataru Otani
Hideyuki Ohi
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Application granted granted Critical
Publication of ATE438722T1 publication Critical patent/ATE438722T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT01930179T 2000-05-17 2001-05-16 Verfahren zur herstellung von proteinen unter reduktion von mannosephosphat in der zuckerkette und dadurch hergestelltes glykoprotein ATE438722T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000144643 2000-05-17
PCT/JP2001/004070 WO2001088143A1 (en) 2000-05-17 2001-05-16 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby

Publications (1)

Publication Number Publication Date
ATE438722T1 true ATE438722T1 (de) 2009-08-15

Family

ID=18651270

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01930179T ATE438722T1 (de) 2000-05-17 2001-05-16 Verfahren zur herstellung von proteinen unter reduktion von mannosephosphat in der zuckerkette und dadurch hergestelltes glykoprotein

Country Status (9)

Country Link
US (3) US7198921B2 (de)
EP (1) EP1283265B1 (de)
JP (2) JP4969011B2 (de)
AT (1) ATE438722T1 (de)
AU (1) AU2001256762A1 (de)
DE (1) DE60139467D1 (de)
DK (1) DK1283265T3 (de)
ES (1) ES2328106T3 (de)
WO (1) WO2001088143A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE438722T1 (de) * 2000-05-17 2009-08-15 Mitsubishi Tanabe Pharma Corp Verfahren zur herstellung von proteinen unter reduktion von mannosephosphat in der zuckerkette und dadurch hergestelltes glykoprotein
CA2434364C (en) 2001-01-19 2013-03-19 The Dow Chemical Company Method for secretory production of glycoprotein having human-type sugar chain using plant cell
CA2551484C (en) 2003-12-24 2015-03-31 Glycofi, Inc. Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins
CN101084233B (zh) * 2004-04-29 2012-08-15 格利科菲公司 用于在糖蛋白产生中减少或消除α-甘露糖苷酶抗性聚糖的方法
CA2623197A1 (en) * 2005-09-22 2007-03-29 Prosci Incorporated Glycosylated polypeptides produced in yeast mutants and methods of use thereof
CA2679732A1 (en) * 2007-03-07 2008-09-18 Glycofi, Inc. Production of glycoproteins with modified fucosylation
EP2134853B1 (de) 2007-04-03 2018-07-18 Oxyrane UK Limited Glycosylierung von molekülen
NZ580510A (en) 2007-04-17 2011-06-30 Stichting Dienst Landbouwkundi Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
US8637435B2 (en) * 2007-11-16 2014-01-28 Merck Sharp & Dohme Corp. Eukaryotic cell display systems
JP5960947B2 (ja) * 2007-12-19 2016-08-02 グライコフィ, インコーポレイテッド タンパク質の製造のための酵母株
JP2011514157A (ja) * 2008-02-20 2011-05-06 グライコフィ, インコーポレイテッド 蛋白質生産用ベクター及び酵母株
EP2263089B1 (de) * 2008-03-03 2015-01-28 GlycoFi, Inc. Oberflächenanzeige rekombinanter proteine bei niederen eukaryoten
US8067339B2 (en) * 2008-07-09 2011-11-29 Merck Sharp & Dohme Corp. Surface display of whole antibodies in eukaryotes
EP2324121B1 (de) 2008-08-12 2012-11-07 GlycoFi, Inc. Verbesserte vektoren und hefestämme zur proteinproduktion: ca2+-atpase-überexpression
EP2401378B1 (de) 2009-02-25 2013-08-14 Merck Sharp & Dohme Corp. Stoffwechselmanipulation eines galaktoseassimilationswegs bei der glycoengineerten hefe pichia pastoris
US9598682B2 (en) 2009-09-29 2017-03-21 Vib Vzw Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose
CN102648286A (zh) 2009-10-16 2012-08-22 默沙东公司 在巴斯德毕赤氏酵母中生产缺乏与针对宿主细胞抗原的抗体的可检测交叉结合活性的蛋白质的方法
AU2010313608A1 (en) 2009-10-30 2012-06-07 Merck Sharp & Dohme Corp. Methods for the production of recombinant proteins with improved secretion efficiencies
US9528116B2 (en) 2009-10-30 2016-12-27 Merck Sharp & Dohme Corp. Method for producing therapeutic proteins in Pichia pastoris lacking dipeptidyl aminopeptidase activity
JP2013511272A (ja) 2009-11-19 2013-04-04 オキシレイン ユーケー リミテッド 哺乳類様複合n−グリカンを生成する酵母株
KR101930961B1 (ko) 2010-02-24 2018-12-19 머크 샤프 앤드 돔 코포레이션 피키아 파스토리스에서 생산된 치료 당단백질 상의 n-글리코실화 부위 점유를 증가시키는 방법
RU2604811C2 (ru) 2010-05-27 2016-12-10 Мерк Шарп Энд Домэ Корп. Способ получения антител с улучшенными свойствами
SG189110A1 (en) 2010-09-29 2013-05-31 Oxyrane Uk Ltd De-mannosylation of phosphorylated n-glycans
WO2012042386A2 (en) 2010-09-29 2012-04-05 Oxyrane Uk Limited Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
WO2012074948A2 (en) 2010-12-01 2012-06-07 Merck Sharp & Dohme Corp. Surface, anchored fc-bait antibody display system
KR20140114278A (ko) 2011-02-25 2014-09-26 머크 샤프 앤드 돔 코포레이션 변형된 o-글리코실화를 갖는 단백질의 생산을 위한 효모 균주
JP2014517846A (ja) 2011-05-25 2014-07-24 メルク・シャープ・アンド・ドーム・コーポレーション 改善された特性を有するFc含有ポリペプチドの製造方法
CA2853341A1 (en) 2011-10-28 2013-05-02 Merck Sharp & Dohme Corp. Engineered lower eukaryotic host strains for recombinant protein expression
JP6194324B2 (ja) 2012-03-15 2017-09-06 オキシレイン ユーケー リミテッド ポンペ病の処置のための方法および材料
US9890378B2 (en) 2012-05-11 2018-02-13 Merck Sharp & Dohme Corp. Surface anchored light chain bait antibody display system
DK2852610T3 (en) 2012-05-23 2018-09-03 Glykos Finland Oy PRODUCTION OF FUCOSYLED GLYCOPROTEIN
US20150275222A1 (en) 2012-10-22 2015-10-01 Bo Jiang Crz1 mutant fungal cells
US9707276B2 (en) 2012-12-03 2017-07-18 Merck Sharp & Dohme Corp. O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues
AU2015293949B2 (en) 2014-07-21 2019-07-25 Teknologian Tutkimuskeskus Vtt Oy Production of glycoproteins with mammalian-like N-glycans in filamentous fungi

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL82935A0 (en) 1986-08-12 1987-12-20 Phillips Petroleum Co Secretion of heterologous proteins from yeast
JPH093097A (ja) * 1995-06-16 1997-01-07 Green Cross Corp:The ピキア属酵母由来の糖鎖伸長タンパク、該蛋白質をコードするdna、修飾該dnaおよび形質転換体
JP2770010B2 (ja) 1996-03-29 1998-06-25 工業技術院長 酵母のマンノース−1−リン酸転移を正に制御する遺伝子ならびにこの遺伝子の欠損変異株を利用する高マンノース型中性糖鎖の製造方法
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
ATE438722T1 (de) * 2000-05-17 2009-08-15 Mitsubishi Tanabe Pharma Corp Verfahren zur herstellung von proteinen unter reduktion von mannosephosphat in der zuckerkette und dadurch hergestelltes glykoprotein
ATE440959T1 (de) * 2000-06-28 2009-09-15 Glycofi Inc Verfahren für die herstellung modifizierter glykoproteine

Also Published As

Publication number Publication date
EP1283265A4 (de) 2004-10-20
ES2328106T3 (es) 2009-11-10
US7872111B2 (en) 2011-01-18
WO2001088143A1 (en) 2001-11-22
US20040014170A1 (en) 2004-01-22
DK1283265T3 (da) 2009-11-09
EP1283265A1 (de) 2003-02-12
AU2001256762A1 (en) 2001-11-26
DE60139467D1 (de) 2009-09-17
JP2012105652A (ja) 2012-06-07
US20070202569A1 (en) 2007-08-30
EP1283265B1 (de) 2009-08-05
JP4969011B2 (ja) 2012-07-04
US7488591B2 (en) 2009-02-10
US7198921B2 (en) 2007-04-03
US20090004725A1 (en) 2009-01-01

Similar Documents

Publication Publication Date Title
DE60139467D1 (de) Verfahren zur herstellung von proteinen unter reduktion von mannosephosphat in der zuckerkette und dadurch hergestelltes glykoprotein
DE60230274D1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des pts-g
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
ATE426021T1 (de) Verfahren zur herstellung von biopterinen
ATE474847T1 (de) Verfahren zur herstellung von dipeptiden
ATE312809T1 (de) Verfahren zur herstellung von gabapentin
DE60211772D1 (de) Verfahren zur Herstellung von Proteine
DE69930938D1 (de) Verfahren zur herstellung eines peptids mit einem pi grösser als 8 oder kleiner als 5
DE60038281D1 (de) Verfahren zur herstellung von optisch aktiven pyridinethanol-derivaten
WO2003040291A3 (de) Gene die für kohlenstoffmetabolismus- und energieproduktion-proteine codieren
ATE235461T1 (de) Verfahren zur herstellung von 3-cyano-2,4- dihalogen-5-fluor-benzoesäuren
ATE386027T1 (de) Verfahren zur herstellung von valsartan
WO1998019160A3 (de) VERFAHREN ZUR INDIREKTEN BESTIMMUNG DER TYP I INTERFERON-PRODUKTION IN VIVO MITTELS ANTIKÖRPER GEGEN HUMANE Mx-PROTEINE SOWIE ANTIKÖRPER HIERZU
DE50109809D1 (de) Verfahren zur Herstellung von D- oder L-Menthol
ATE341558T1 (de) Verfahren zur herstellung von topiramate
ATE458037T1 (de) Grosstechnisch geeigneter mikroorganismus
ATE386015T1 (de) Verfahren zur herstellung von alkyl-n-(3- dimethylamino)alkylcarbamaten
ATE399209T1 (de) Verfahren zur herstellung von coenzym q 10
DE69930118D1 (de) Verfahren zur herstellung von proteinen in transformierten hefezellen
WO2003040289A3 (de) Gene die für dna-replikations- und pathogenese proteine codieren
DE602005016857D1 (de) Verfahren zur Herstellung von Tripeptid-Zwischenprodukten zur Herstellung von LHRH-Antagonisten
DE50203529D1 (de) Verfahren zur herstellung von desclarithromycin, sowie zwischenprodukte
DE60307296D1 (de) Verfahren zur herstellung von vitamin-b6
ATE316146T1 (de) Verfahren zur herstellung von pravastatin- natriumsalz mittels streptomyces flavidovirens dsm 14455

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties